News

Celebrating high achievers: Emily Kibble

Early Career Research Award – Winner: Emily Kibble

Miss Emily Kibble was the recipient of the Early Career Award at the 2020 DMTC Annual Conference. She is currently a PhD candidate in molecular biology at Murdoch University.

PhD candidate and Early Career Research Award winner Emily Kibble with CEO DMTC, Dr Mark Hodge

Emily has produced outstanding work over the last few years in her PhD and contributed significantly to the DMTC collaborative project led by the University of Western Australia, along with DST Group, the Peter Doherty Institute, the University of Wurzburg, the University of Exeter, DSTL and now Monash University. This project focuses on the development of novel anti-virulence compounds against a range of bio-warfare pathogens.

Emily’s PhD research examines the pathogen Neisseria meningitidis, which causes meningococcal disease. In particular, it focuses on the inhibition of a protein called Mip, which appears to be key for the bacteria’s development and infectivity. This inhibition could become a target for viable treatments and is highly important as there has been little research into Mip protein function in this particular pathogen.

In addition to this research, Emily has developed a novel screening mechanism to reduce the time required to test anti-virulence inhibitors against pathogens, increasing the efficiency of the testing process.

As well as receiving this award from DMTC, Emily was awarded the Australian Industry and Defence Network (AIDN) Young Achiever of the Year Award in 2018. Her contribution to DMTC has been significant, and she is very deserving of this award.

More detail on Emily’s work is available in this recent blog post.

High honours for brilliant research and industrial partnerships

DMTC Limited has honoured the work of industrially focused research teams and individuals at its 2020 Awards for Excellence.

Technology development and innovation in areas as diverse as digitisation of defence equipment, aircraft maintenance and medical countermeasure development were acknowledged with awards. (more…)

Risk and reward in industrial innovation

Writing for the Australian Financial Review, DMTC CEO Dr Mark Hodge discussed the importance of getting the macro, national policy settings right as an enabler of successful innovation and technology development activities in Australia’s defence and national security sectors.

(more…)

DMTC 2020 Annual Conference

DMTC’s 2020 Annual Conference will be held on 11-12 March at The Realm Hotel in Canberra.

Our Annual Conference and Awards Dinner has become a key event for the DMTC community, providing the opportunity to highlight the relevance of our work in the context of developing sovereign industrial capabilities within the defence industry sector.

The 2020 conference is expected to feature keynote presentations from prominent Defence and industry guest speakers, and include outlines of the technological challenges and priorities across the defence and national security sectors.

More details will be available here as they are released.

The Fine Print

Numbers are strictly limited and will be managed on an invite-only basis, with preference given to DMTC project team members and partner representatives.  Some presentations may include DMTC-in-confidence technical details. For both of these reasons a public call for registrations will not be made, however expressions of interest in attending can be submitted and may result in you receiving an invitation to attend.

Support from our sponsors

DMTC gratefully acknowledges the support we have received from a number of organisations in making the 2020 Annual Conference a reality.

Contacts

For enquiries about registration or sponsorships please contact the DMTC Head Office on (03) 9214 4447 or send an email to information@dmtc.com.au.

For enquiries from media outlets or organisations please contact Harry Baxter on 0401 516 734.